David Rendall - 18 Jun 2021 Form 4 Insider Report for PURE BIOSCIENCE, INC. (PURE)

Role
Director
Signature
/s/ David Rendall
Issuer symbol
PURE
Transactions as of
18 Jun 2021
Net transactions value
$0
Form type
4
Filing time
24 Jun 2021, 19:36:44 UTC
Previous filing
24 Jun 2021
Next filing
19 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PURE Stock Option (Right to Buy) Award $0 +100,000 $0.000000 100,000 18 Jun 2021 Common Stock 100,000 $0.4500 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2022 or January 15, 2022 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2023 or January 15, 2023.